ZA201601775B - Method for the synthesis of irinotecan - Google Patents
Method for the synthesis of irinotecanInfo
- Publication number
- ZA201601775B ZA201601775B ZA2016/01775A ZA201601775A ZA201601775B ZA 201601775 B ZA201601775 B ZA 201601775B ZA 2016/01775 A ZA2016/01775 A ZA 2016/01775A ZA 201601775 A ZA201601775 A ZA 201601775A ZA 201601775 B ZA201601775 B ZA 201601775B
- Authority
- ZA
- South Africa
- Prior art keywords
- irinotecan
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 title 1
- 229960004768 irinotecan Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13195464.6A EP2881396A1 (en) | 2013-12-03 | 2013-12-03 | Method for the synthesis of irinotecan |
PCT/EP2014/075369 WO2015082240A1 (en) | 2013-12-03 | 2014-11-24 | Method for the synthesis of irinotecan |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201601775B true ZA201601775B (en) | 2017-07-26 |
Family
ID=49683603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2016/01775A ZA201601775B (en) | 2013-12-03 | 2016-03-15 | Method for the synthesis of irinotecan |
Country Status (23)
Country | Link |
---|---|
US (1) | US9765083B2 (ru) |
EP (2) | EP2881396A1 (ru) |
JP (1) | JP6200084B2 (ru) |
KR (1) | KR101813423B1 (ru) |
CN (1) | CN105636963B (ru) |
AU (1) | AU2014359552B2 (ru) |
BR (1) | BR112016012717A2 (ru) |
CA (1) | CA2924256C (ru) |
DK (1) | DK3030567T3 (ru) |
ES (1) | ES2606771T3 (ru) |
HK (1) | HK1220969A1 (ru) |
HU (1) | HUE032281T2 (ru) |
IL (1) | IL244487B (ru) |
MX (1) | MX2016005065A (ru) |
NZ (1) | NZ717802A (ru) |
PL (1) | PL3030567T3 (ru) |
PT (1) | PT3030567T (ru) |
RS (1) | RS55483B1 (ru) |
RU (1) | RU2648989C2 (ru) |
SI (1) | SI3030567T1 (ru) |
UA (1) | UA114155C2 (ru) |
WO (1) | WO2015082240A1 (ru) |
ZA (1) | ZA201601775B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2881396A1 (en) | 2013-12-03 | 2015-06-10 | Synbias Pharma AG | Method for the synthesis of irinotecan |
CN111362960A (zh) * | 2018-12-25 | 2020-07-03 | 华北制药集团新药研究开发有限责任公司 | 一种伊立替康-y的制备方法 |
CN115073483B (zh) * | 2022-07-27 | 2022-10-25 | 泽升科技(广州)有限公司 | 一种伊立替康的对映体的制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4473692A (en) | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
JPS6019790A (ja) | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
JPS6185319A (ja) * | 1984-10-03 | 1986-04-30 | Yakult Honsha Co Ltd | 抗腫瘍剤 |
JP2848958B2 (ja) * | 1990-09-28 | 1999-01-20 | スミスクライン・ビーチャム・コーポレイション | 水溶性カンプトテシン類似体、方法および手段 |
RU2287527C2 (ru) * | 2002-04-17 | 2006-11-20 | Фармация Корпорейшн | Соединения, используемые при получении производных камптотецина |
WO2004069201A2 (en) * | 2003-02-03 | 2004-08-19 | Medlogics Device Corporation | Compounds useful in coating stents to prevent and treat stenosis and restenosis |
CA2523059A1 (en) | 2003-05-12 | 2004-11-25 | Scinopharm Taiwan, Ltd. | Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin |
CZ299329B6 (cs) * | 2003-08-26 | 2008-06-18 | Pliva-Lachema A.S. | Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu |
CZ299593B6 (cs) | 2003-12-16 | 2008-09-10 | Pliva-Lachema A. S. | Zpusob výroby 7-ethyl-10-hydroxykamptothecinu |
US20050272757A1 (en) * | 2004-06-04 | 2005-12-08 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
US20080182990A1 (en) * | 2004-08-09 | 2008-07-31 | Shilpa Medicare Limited | Process for the Preparation of Irinotecan Hydrochloride Trihydrate |
US20070208050A1 (en) * | 2006-02-24 | 2007-09-06 | Palle Venkata Raghavendra Acha | Process for preparing irinotecan |
WO2008035377A2 (en) * | 2006-09-18 | 2008-03-27 | Shilpa Medicare Ltd. | Novel intermediates for the preparation of camptothecin analogues |
CN101314587B (zh) * | 2007-05-31 | 2010-10-27 | 上海金和生物技术有限公司 | 一种伊立替康的中间体及其制备方法和伊立替康的制备方法 |
US8546573B2 (en) * | 2009-11-18 | 2013-10-01 | Cadila Healthcare Limited | Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate |
CN102718772A (zh) * | 2012-04-17 | 2012-10-10 | 肖文辉 | 一类羟喜树碱衍生物和其制剂的制备及临床应用 |
EP2881396A1 (en) | 2013-12-03 | 2015-06-10 | Synbias Pharma AG | Method for the synthesis of irinotecan |
-
2013
- 2013-12-03 EP EP13195464.6A patent/EP2881396A1/en not_active Withdrawn
-
2014
- 2014-11-24 JP JP2016528014A patent/JP6200084B2/ja not_active Expired - Fee Related
- 2014-11-24 AU AU2014359552A patent/AU2014359552B2/en not_active Ceased
- 2014-11-24 EP EP14802435.9A patent/EP3030567B1/en not_active Not-in-force
- 2014-11-24 PT PT148024359T patent/PT3030567T/pt unknown
- 2014-11-24 ES ES14802435.9T patent/ES2606771T3/es active Active
- 2014-11-24 MX MX2016005065A patent/MX2016005065A/es unknown
- 2014-11-24 PL PL14802435T patent/PL3030567T3/pl unknown
- 2014-11-24 UA UAA201602908A patent/UA114155C2/uk unknown
- 2014-11-24 DK DK14802435.9T patent/DK3030567T3/en active
- 2014-11-24 CA CA2924256A patent/CA2924256C/en not_active Expired - Fee Related
- 2014-11-24 SI SI201430102A patent/SI3030567T1/sl unknown
- 2014-11-24 WO PCT/EP2014/075369 patent/WO2015082240A1/en active Application Filing
- 2014-11-24 CN CN201480055325.8A patent/CN105636963B/zh not_active Expired - Fee Related
- 2014-11-24 RU RU2016109643A patent/RU2648989C2/ru not_active IP Right Cessation
- 2014-11-24 NZ NZ717802A patent/NZ717802A/en not_active IP Right Cessation
- 2014-11-24 RS RS20161119A patent/RS55483B1/sr unknown
- 2014-11-24 US US15/023,827 patent/US9765083B2/en not_active Expired - Fee Related
- 2014-11-24 HU HUE14802435A patent/HUE032281T2/en unknown
- 2014-11-24 BR BR112016012717-0A patent/BR112016012717A2/pt not_active IP Right Cessation
- 2014-11-24 KR KR1020167013893A patent/KR101813423B1/ko active IP Right Grant
-
2016
- 2016-03-08 IL IL244487A patent/IL244487B/en not_active IP Right Cessation
- 2016-03-15 ZA ZA2016/01775A patent/ZA201601775B/en unknown
- 2016-07-27 HK HK16108991.4A patent/HK1220969A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2881396A1 (en) | 2015-06-10 |
US9765083B2 (en) | 2017-09-19 |
IL244487B (en) | 2019-07-31 |
RU2648989C2 (ru) | 2018-03-29 |
US20160264590A1 (en) | 2016-09-15 |
KR101813423B1 (ko) | 2017-12-28 |
DK3030567T3 (en) | 2016-12-19 |
HUE032281T2 (en) | 2017-09-28 |
AU2014359552B2 (en) | 2017-03-30 |
SI3030567T1 (sl) | 2017-01-31 |
CA2924256C (en) | 2018-09-18 |
BR112016012717A2 (pt) | 2020-08-11 |
JP6200084B2 (ja) | 2017-09-20 |
WO2015082240A1 (en) | 2015-06-11 |
PT3030567T (pt) | 2016-12-15 |
CN105636963B (zh) | 2018-07-03 |
UA114155C2 (xx) | 2017-04-25 |
EP3030567A1 (en) | 2016-06-15 |
HK1220969A1 (zh) | 2017-05-19 |
NZ717802A (en) | 2017-06-30 |
IL244487A0 (en) | 2016-04-21 |
CN105636963A (zh) | 2016-06-01 |
ES2606771T3 (es) | 2017-03-27 |
RS55483B1 (sr) | 2017-04-28 |
MX2016005065A (es) | 2016-07-19 |
KR20160091907A (ko) | 2016-08-03 |
JP2016539107A (ja) | 2016-12-15 |
CA2924256A1 (en) | 2015-06-11 |
PL3030567T3 (pl) | 2017-06-30 |
EP3030567B1 (en) | 2016-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201421334D0 (en) | Synthesis of aeizeolite | |
HK1216429A1 (zh) | 用於純化芳基硫酸酯酶 的方法 | |
IL240742A0 (en) | Methods for generating libraries for directed evolution | |
IL245457B (en) | Production method for iopamidol | |
HK1214240A1 (zh) | 用於製備酰亞胺基二硫酰化合物的方法 | |
IL245474B (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
IL245476B (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
ZA201603457B (en) | Novel method for the synthesis of agomelatine | |
PL2821393T3 (pl) | Sposób syntezy związków azowych | |
HK1220969A1 (zh) | 用於合成伊立替康的方法 | |
IL229326A (en) | Process for making n-iodine-affluent | |
PT2799426T (pt) | Novo processo para a síntese de aminaftona | |
HK1217323A1 (zh) | 異己糖醇單三氟甲磺酸酯及其合成方法 | |
IL239815A0 (en) | Process for preparing derivatives of 4-methylpent-3-en-1-ol | |
GB201323123D0 (en) | Method for the preparation of biopolymers | |
PL2757513T3 (pl) | Sposób naliczania opłat za korzystanie z infrastruktury drogowej | |
HK1216419A1 (zh) | 合成方法 | |
EP2947075A4 (en) | PROCESS FOR THE SYNTHESIS OF THIADIAZOLYLAMIDE DERIVATIVE | |
IL246188B (en) | A process for the preparation of tiacomycin | |
IL244411B (en) | Procedure for the synthesis of derivatives of n-benzyl-n-cyclopropyl-1h-pyrazole-4-carboxamide | |
SG10201701021XA (en) | Method of synthesis |